Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 22,009 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Financial Burden, Financial Toxicity, Financial Stress, Financial Navigation, Gynecologic Cancers, Caregiver Burnout
Interventions: Educational Intervention; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Posttraumatic Stress Disorder, Depression
Interventions: Self-Help Cognitive Processing Therapy, Women Veterans Network (WoVeN), Treatment as Usual; Behavioral · Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Oral Leukoplakia
Interventions: pioglitazone-metformin; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Dry Eye Syndrome (DES), Meibomian Gland Dysfunction (Disorder)
Interventions: Manual expression of meibomian glands after thermal eyelid therapy; Device
Lead sponsor: Cleveland Eye Clinic; Other
Eligibility: 50 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Largo, Florida • Brecksville, Ohio

Conditions: Racially/Ethnically Diverse Families From Urban Settings
Interventions: No intervention; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 8 Years to 18 Years
Enrollment: 631 participants
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: Athens, Georgia • Minneapolis, Minnesota

Conditions: Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome
Interventions: Buccal swab saliva for further genetic testing; Genetic
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 1 Day to 5 Days
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Bone Marrow Failure Syndromes, Erythrocyte Disorder, Leukocyte Disorder, Hemostasis, Blood Coagulation Disorder, Sickle Cell Disease, Dyskeratosis Congenita, Diamond-Blackfan Anemia, Congenital Thrombocytopenia, Severe Congenital Neutropenia, Fanconi Anemia, Myelodysplastic Syndromes, Myeloproliferative Diseases
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 1,716 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2050
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Prostate Cancer, Supportive Care
Interventions: Exercise Training Intervention, Healthy Living Education; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Richmond, Virginia

Conditions: Colon Adenoma, Colon Polyp, Colon Lesion
Interventions: Endoscopic tissue resection; Procedure
Lead sponsor: University of British Columbia; Other
Eligibility: 18 Years and older
Enrollment: 3,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Saint Cloud, Minnesota

Conditions: Melanoma (Skin), Skin Cancer
Interventions: RAYS Intervention; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 3 Years to 7 Years
Enrollment: 843 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 2
States / cities: Salt Lake City, Utah • Morgantown, West Virginia

Conditions: Post-Bariatric Hypoglycemia
Interventions: Use of Continuous Glucose Monitor (CGM), Use of "Cardea Solo" monitoring; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Physical Activity, Sedentary Behavior, Gestational Weight Gain, Social Determinants of Health
Interventions: #BabyLetsMove; Behavioral
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 15 Years to 19 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Lymphatic Malformation
Interventions: TARA-002; Biological
Lead sponsor: Protara Therapeutics; Industry
Eligibility: 6 Months to 18 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 11
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Aurora, Colorado + 8 more

Conditions: Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea, Clostridia Difficile Colitis
Interventions: Alanyl-glutamine; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 105 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Charlottesville, Virginia • Roanoke, Virginia

Conditions: Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant, Medication Nonadherence, Health Behavior, Remote Monitoring, Patient Engagement
Interventions: DOT intervention; Other
Lead sponsor: University of Florida; Other
Eligibility: 10 Years to 21 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: Coral Gables, Florida • Gainesville, Florida • Hollywood, Florida + 1 more

Conditions: Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), TP53-mutated MDS and AML
Interventions: CLN-049; Drug
Lead sponsor: Cullinan Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 17
States / cities: Birmingham, Alabama • Phoenix, Arizona • Duarte, California + 13 more

Conditions: Myelofibrosis
Interventions: ropeginterferon alfa- 2b, Ruxolitinib; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)
Interventions: transdermal 17β-E2 with cyclic progestin, oral 17β-E2 with cyclic progestin, transdermal EE+LNG; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 14 Years to 30 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Charlottesville, Virginia

Conditions: Allogeneic Stem Cell Transplant Recipient
Interventions: Fludarabine, Intermediate-dose Total Body Irradiation (TBI), Post-transplant Cyclophosphamide (PTCy), Tacrolimus, Mycophenolate mofetil (MMF); Drug · Radiation
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Hackensack, New Jersey • Neptune City, New Jersey

Conditions: Treatment Adherence
Interventions: HT Helper app use plus patient navigation support, Patient Navigation support alone, Usual Care; Behavioral · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Gliomas
Interventions: Ulixertinib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma, Skin Cancer
Interventions: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2; Biological · Drug
Lead sponsor: Karam Khaddour, MD, MS; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Feasibility Studies, Physical Activity, Mental Health (Depression), Anxiety, Quality of Life
Interventions: Fitness app powered by AI and wearable device; Other
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Cerebral Palsy (CP), Dysarthria
Interventions: Speech only, Hand/Arm only, Speech and arm combined; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 8 Years to 17 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Newark, New Jersey

Search by objective public record fields.

Proactive Costs of Care Study

Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

A Multi Center Evaluation of TearCare on Surgical Measurements Before Cataract Surgery

Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families

MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

Investigation of the Genetics of Hematologic Diseases

Behavioral Exercise Training to Reduce Cardiovascular Disease Risk

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)

Rural Adult and Youth Sun Protection Study

Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia

Teen Mom Study Feasibility Trial

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis

Role of Estrogen on Skeletal Outcomes in FHA

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

TIL Therapy in cSCC and MCC

AI-Based Personalized Exercise Prescription Through Mobile Health on Physical Activity and Health Outcomes in Older Adults: A Feasibility Study

Speech and Arm Combined Exergame